Cargando…
HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice
BACKGROUND: Hepatocellular carcinoma (HCC) is a frequently diagnosed cancer and a leading cause of cancer-related death worldwide. Its rapid progression, combined with the limited treatment options at late stages, imposes the need for early detection and aggressive intervention. Based on the knowled...
Autores principales: | Afaloniati, Hara, Angelopoulou, Katerina, Giakoustidis, Alexander, Hardas, Alexandros, Pseftogas, Athanasios, Makedou, Kali, Gargavanis, Athanasios, Goulopoulos, Thomas, Iliadis, Stavros, Papadopoulos, Vasileios, Papalois, Apostolos, Mosialos, George, Poutahidis, Theofilos, Giakoustidis, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304783/ https://www.ncbi.nlm.nih.gov/pubmed/32606772 http://dx.doi.org/10.2147/OTT.S250233 |
Ejemplares similares
-
Targeting hepatocarcinogenesis model in C56BL6 mice with pan-aurora kinase inhibitor Danusertib
por: Gavriilidis, Paschalis, et al.
Publicado: (2018) -
Inhibition of γδ-TcR or IL17a Reduces T-Cell and Neutrophil Infiltration after Ischemia/Reperfusion Injury in Mouse Liver
por: Al Mogrampi, Saant, et al.
Publicado: (2023) -
The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGFβ Signaling
por: Pseftogas, Athanasios, et al.
Publicado: (2020) -
Undifferentiated embryonal sarcoma of the liver in a young female: treatment with portal vein embolization and liver trisectonectomy
por: Giakoustidis, Dimitrios E., et al.
Publicado: (2016) -
Primary gigantic leiomyosarcoma of the liver treated with portal vein embolization and liver resection
por: Giakoustidis, Dimitrios, et al.
Publicado: (2017)